top of page
mmCloud
_tiff.png)
MassMatrix's mmCloud is a Multiomic Data Science Cloud Platform Unifying & Simplifying Life Science R&D
mmCloud provides solutions for analysis of Mass Spectrometry data (Proteomics, RNA/DNA Sequencing, Metabolomics) & Transcriptomics data from next-gen sequencing.
Multiomic Pipelines
Reproducible Workflows
Scalable Platform
Dynamic Visualizations
Custom Analysis
mmCloud
Secure Scalable High-throughput
Simplify and Focus on the Science
Collaborate and Access from anywhere
access all relevant data via data science dashboards and RESTful API
mm1
Fireside chat about mmCloud
Professor Mike Freitas , explaining how mmCloud can help in the research and analysis process
About
mmSearch
Protiens
How it works
Upload your data to mmCloud.
Select a Proteomics workflow to run
Get Results
Analyze and Visualize
Identify Proteins, Peptides, PTMs, Disulphide bonds and Crosslinks
mmSearch
.png)
Dynamic Visualizations
Scalable Platform
mmOligo
Ask us about conjugates!
Mass spec-based Oligonucleotide workflow
Identify modifications
Verify sequences & identify impurities
Modification, truncation and mutation analysis
Hybrid RNA / DNA
Automatically screen data for synthesis and manufacturing impurities via blind mutation analysis
RNA/DNA sequencing mmOligo on mmCloud is a revolutionary new way to study oligonucleotides
mmOligo simplifies the analysis of complex highly modified RNA/DNA sequencing. Our solution will transform your complex mass spectrometry data into easily interpreted sequencing results, and greatly simplifies the important task of identification and quantification of impurities. Our versatile approach to sequencing can handle even more complex conjugated biomolecules
mmOligo
Anchor 1
Services
Team
mmTeam
G. Hall Johnson
Co-founder & Chief Executive Officer
Michael Freitas, PhD
Co-founder & Chief Science Officer
Shay Reddy
Chief Operating Officer
Contact
Supercharge your Workflows
NIH Grant awardee and industry leading partners
"Accelerating Site-specific Characterization of Protein Therapeutics with Novel Machine Learning Methods"
(Research supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R44GM131484 (Phase II SBIR Grant). The content is solely the responsibility of MassMatrix and does not necessarily represent the official views of the National Institutes of Health.)
bottom of page